AGC Biologics A/S

AGC Biologics A/S (CVR number: 25950941) is a company from GLADSAXE. The company reported a net sales of 2518 mDKK in 2022, demonstrating a growth of 15.2 % compared to the previous year. The operating profit percentage was at 31.5 % (EBIT: 793.5 mDKK), while net earnings were 598.9 mDKK. The profitability of the company measured by Return on Assets (ROA) was 24.1 %, which can be considered excellent and Return on Equity (ROE) was 92.5 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 31.4 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. AGC Biologics A/S's liquidity measured by quick ratio was 1.6 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.